CNE100000Q84
CNE100000Q84
ANDON HEALTH
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 27.64B EUR | 32.94B EUR | 34.22B EUR | 18.62B EUR |
Enterprise Value | 24.1B EUR | 38.77B EUR | 37.76B EUR | 20.97B EUR |
Valuation Multiples | ||||
Trailing P/E | 5.68x | 8.79x | 21.06x | 11.65x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 24.43x | 39.8x | 39.98x | 17.54x |
Price to Book | 1.08x | 1.42x | 1.58x | 0.85x |
EV/Revenue | 21.3x | 46.85x | 44.11x | 19.76x |
EV/EBITDA | -97.2x | 577.15x | 138.67x | 49.17x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -1.01% | -1.14% | -1.08% | -1.18% |